Reticulated platelets – a new risk factor of atherothrombosis?
Open Access
- 13 July 2021
- journal article
- review article
- Published by Remedium, Ltd. in Atherothrombosis
- No. 1,p. 144-156
Abstract
In this review we described the properties of reticulated platelets (RP) and showed how variations of their content might influence platelet activity, efficacy of antiplatelet drugs and the rate of thrombotic events in patients with cardiovascular diseases. RP represent a minor platelet fraction containing residual RNA from megakaryocytes. Platelets have no nucleus and do not synthesize RNA de novo, and RNA of megakaryocytic origin is destroyed during their circulation. That is why only recently produced “young” platelets contain RNA. In healthy donors RP are identified by staining with the RNA specific fluorescent dyes by flow cytofluorimetry or using standard protocols in modern flow haematological analyzers. RP content in blood reflects the level of thrombocytopoesis in the bone marrow. RP on average amounted from 3 to 10% of all platelets in the circulation depending on the method applied for their determination. RP absolute amount and/or their percentage is changed in haematological diseases associated with the alterations of megakaryocyte productive properties. RT measurements in patients with cardiovascular diseases have shown that their content is increased in acute coronary syndrome patients. RP are larger and functionally more active in comparison with not reticulated forms. They more frequently incorporate into the platelet aggregates and contain more intracellular granules. Increase of RT content in the circulation correlates with the increase of the average size and functional activity in the whole platelet population. High RP content in patients with cardiovascular diseases reduces antiaggregative effects of aspirin and P2Y12 APD receptor antagonists and increases the risk of atherothrombotic events.Keywords
This publication has 57 references indexed in Scilit:
- Reticulated Platelets in Medicine: Current Evidence and Further PerspectivesJournal of Clinical Medicine, 2020
- Reticulated platelets and immature platelet fraction: Clinical applications and method limitationsInternational Journal of Laboratory Hematology, 2020
- Reticulated platelets: analytical aspects and clinical utilityClinical Chemistry and Laboratory Medicine (CCLM), 2014
- Reticulated platelets and uninhibited COX‐1 and COX‐2 decrease the antiplatelet effects of aspirinJournal of Thrombosis and Haemostasis, 2007
- Measurement of reticulated platelets by simple flow cytometry: An indirect thrombocytopoietic markerEuropean Journal of Internal Medicine, 2006
- A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF)Thrombosis Research, 2006
- Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attackBritish Journal of Haematology, 2004
- Diagnostic Value of Tests for Reticulated Platelets, Plasma Glycocalicin, and Thrombopoietin Levels for Discriminating Between Hyperdestructive and Hypoplastic ThrombocytopeniaAmerican Journal of Clinical Pathology, 2001
- Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disordersBlood, 1990
- Reticulated Platelets following Acute Blood LossBritish Journal of Haematology, 1969